We show you our most important and recent visitors news details US FDA authorizes Pfizer's Covid-19 vaccine for use in people ages 12 to 15 in the following article
Hind Al Soulia - Riyadh - WASHINGTON — The US Food and Drug Administration has expanded the emergency use authorization for Pfizer's COVID-19 vaccine to include people ages 12 to 15.
To support the extended use, the FDA reviewed data submitted by Pfizer. The company said at the end of March that a clinical trial involving 2,260 12-to-15-year-olds showed the vaccine's efficacy is 100 percent and it is well tolerated.
The FDA's independent Vaccines and Related Biological Products Advisory Committee did not meet to vote on whether to recommend the expansion of the EUA to 12-to-15-year-olds. But the US Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices is scheduled to meet Wednesday to advise CDC on whether to recommend the use of the vaccine in this age group. CDC Director Dr. Rochelle Walensky will then decide whether the agency will recommend the vaccine's use in the new group.
Expanding authorization to people 12 to 15 opens COVID-19 vaccination to another 5 percent of the US population, nearly 17 million more people. The expanded authorization means 85 percent of the US population is eligible to receive a COVID vaccine.
Pfizer said last week it expects to submit for emergency use authorization for its COVID-19 vaccine for children ages 2 to 11 years old in September. Its vaccine safety and efficacy study in children ages 6 months to 11 years old is ongoing.
The FDA also scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee for June 10 to discuss the potential extension of EUA to children under 12.
"During the meeting, the agency will provide a status update on our approach to emergency use authorization (EUA) for COVID-19 vaccines intended for use in individuals 12 through 17 years of age," the FDA said in a statement.
"The committee will also discuss the data needed to support a EUA and a biologics license application (BLA) for a COVID-19 vaccine intended for use in children less than 12 years of age. The committee will not discuss any specific products," it added.
Vaccines made by Moderna and by Johnson & Johnson are currently authorized for use in people 18 and older.
"As with the initial COVID-19 vaccine authorizations, we want to ensure that the public has a clear understanding of our expectations for the data and information needed to support requests for emergency use authorization and biologics license applications for vaccines intended to prevent COVID-19 in this pediatric age range." — CNN
These were the details of the news US FDA authorizes Pfizer's Covid-19 vaccine for use in people ages 12 to 15 for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Saudi Gazette and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.